Cameron John Reynolds Volitionrx LTD (VNRX) insider trading activity

VNRX Quotes by TradingView

Cameron John Reynolds is President and CEO of VOLITIONRX LTD. Currently has a direct ownership of 2.55 Million shares of VNRX, which is worth approximately $843,099. The most recent transaction as insider was on Nov 17, 2025, when has been sold 20,000 shares (Common Stock) at a price of $0.35 per share, resulting in proceeds of $7,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.55M
2.67% 3M change
20.66% 12M change
Total Value Held $843,099

Cameron John Reynolds Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2025
BUY
Open market or private purchase
$7,000 $0.35 p/Share
20,000 Added 0.78%
2,554,847 Common Stock
Oct 14 2025
BUY
Open market or private purchase
$56,100 $0.51 p/Share
110,000 Added 4.16%
2,534,847 Common Stock
Sep 12 2025
BUY
Open market or private purchase
$9,900 $0.66 p/Share
15,000 Added 0.57%
2,624,847 Common Stock
Aug 05 2025
BUY
Open market or private purchase
$50,000 $0.64 p/Share
78,125 Added 2.91%
2,609,847 Common Stock
Jul 24 2025
BUY
Grant, award, or other acquisition
-
200,000 Added 7.32%
2,531,722 Common Stock
Jun 12 2025
BUY
Open market or private purchase
$7,375 $0.59 p/Share
12,500 Added 0.53%
2,331,722 Common Stock
May 19 2025
BUY
Open market or private purchase
$8,800 $0.44 p/Share
20,000 Added 0.85%
2,319,222 Common Stock
Mar 26 2025
BUY
Open market or private purchase
$99,999 $0.55 p/Share
181,818 Added 7.33%
2,299,222 Common Stock
Dec 09 2024
BUY
Open market or private purchase
$79,692 $0.57 p/Share
139,811 Added 6.19%
2,117,404 Common Stock
Sep 01 2024
BUY
Grant, award, or other acquisition
-
103,243 Added 4.96%
1,977,593 Common Stock
Aug 15 2024
BUY
Grant, award, or other acquisition
-
29,500 Added 1.55%
1,874,350 Common Stock
Jun 01 2024
BUY
Grant, award, or other acquisition
-
90,182 Added 4.66%
1,844,850 Common Stock
Jan 24 2024
BUY
Grant, award, or other acquisition
-
50,150 Added 2.78%
1,754,668 Common Stock
Dec 08 2023
BUY
Open market or private purchase
$6,700 $0.67 p/Share
10,000 Added 0.58%
1,704,518 Common Stock
Oct 19 2023
BUY
Grant, award, or other acquisition
-
200,000 Added 10.56%
1,694,518 Common Stock
Aug 16 2023
BUY
Open market or private purchase
$12,200 $1.22 p/Share
10,000 Added 0.66%
1,494,518 Common Stock
Jul 05 2023
BUY
Grant, award, or other acquisition
-
40,050 Added 2.63%
1,484,518 Common Stock
Jan 12 2023
BUY
Grant, award, or other acquisition
-
33,375 Added 2.26%
1,444,468 Common Stock
Oct 13 2022
BUY
Grant, award, or other acquisition
-
15,575 Added 1.09%
1,411,093 Common Stock
Oct 04 2022
BUY
Grant, award, or other acquisition
-
200,000 Added 12.54%
1,395,518 Common Stock
Aug 30 2022
BUY
Open market or private purchase
$5,635 $1.61 p/Share
3,500 Added 0.29%
1,195,518 Common Stock
Jun 23 2022
BUY
Grant, award, or other acquisition
-
32,270 Added 2.64%
1,192,018 Common Stock
Apr 07 2022
BUY
Grant, award, or other acquisition
-
17,375 Added 1.48%
1,159,748 Common Stock
CJR

Cameron John Reynolds

President and CEO
Henderson, NV

Track Institutional and Insider Activities on VNRX

Follow VOLITIONRX LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNRX shares.

Notify only if

Insider Trading

Get notified when an Volitionrx LTD insider buys or sells VNRX shares.

Notify only if

News

Receive news related to VOLITIONRX LTD

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VNRX